Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by stockman75on Feb 10, 2017 9:40am

124 Views

Post# 25827543

RE:RE:RE:Why all the moaning

Speaking for myself... I had bought high and was way overweighted. Yes I could have bought more and more to average down. So what you are saying is true and valid if you nibble and nibble..

I made mistake buying way too much at one point in time and was at a point I did not want to lose any more should the ship tank and certainly before Ibalzimubab it wasn't looking too hot.

Bullboard Posts

Catch up with companies that got a Stanley Cup Playoffs boost